Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
Some years ago, excipients were considered inert substances irrelevant in the absorption process. However, years of study have demonstrated that this belief is not always true. In this study, the reasons for a bioequivalence failure between two formulations of silodosin are investigated. Silodosin i...
Saved in:
Main Authors: | Isabel González-Álvarez (Author), Bárbara Sánchez-Dengra (Author), Raquel Rodriguez-Galvez (Author), Alejandro Ruiz-Picazo (Author), Marta González-Álvarez (Author), Alfredo García-Arieta (Author), Marival Bermejo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
by: Isabel Gonzalez-Alvarez, et al.
Published: (2021) -
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
by: Isabel Gonzalez-Alvarez, et al.
Published: (2024) -
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole
by: Gema J. Cabañero-Resta, et al.
Published: (2024) -
Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses
by: Marival Bermejo, et al.
Published: (2019) -
Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat
by: Bárbara Sánchez-Dengra, et al.
Published: (2021)